Mirum Pharmaceuticals Inc (NAS:MIRM)
$ 41.56 -0.47 (-1.12%) Market Cap: 2.02 Bil Enterprise Value: 2.06 Bil PE Ratio: 0 PB Ratio: 8.69 GF Score: 51/100

Mirum Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 28, 2023 / 03:30PM GMT
Release Date Price: $31.56 (+2.47%)
Josh Schimmer
Cantor Fitzgerald, L.P. - Moderator

Welcome, everyone. I'm Josh Schimmer from the Cantor biotech equity research team. Very pleased to introduce, from Mirum Pharmaceuticals, we have Eric Bjerkholt, the brand-new Chief Financial Officer; and Andrew McKibben, Vice President of Investor Relations and Finance, so welcome.

Questions & Answers

Josh Schimmer
Cantor Fitzgerald, L.P. - Moderator

Lots of change in a short period of time at Mirum. Eric, why don't we start with you, as you're coming in, new to the company? Maybe talk a little bit about your near-term and long-term objectives.

Eric Bjerkholt
Mirum Pharmaceuticals, Inc. - CFO

Sure. Thank you and thank you for having us. And before I answer your question, let me say, we will be making forward-looking statements, so please refer to our SEC filings for the risk factors.

Let me start by saying I'm incredibly impressed by what this management team has accomplished in just a few years. And in fact, that made it very attractive for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot